nodes	percent_of_prediction	percent_of_DWPC	metapath
Ganciclovir—Splenomegaly—Propylthiouracil—Graves' disease	0.121	0.121	CcSEcCtD
Ganciclovir—Aplastic anaemia—Methimazole—Graves' disease	0.0371	0.0371	CcSEcCtD
Ganciclovir—Vasculitis—Propylthiouracil—Graves' disease	0.0345	0.0345	CcSEcCtD
Ganciclovir—Lymphadenopathy—Methimazole—Graves' disease	0.0337	0.0337	CcSEcCtD
Ganciclovir—Aplastic anaemia—Propylthiouracil—Graves' disease	0.0316	0.0316	CcSEcCtD
Ganciclovir—Lymphadenopathy—Propylthiouracil—Graves' disease	0.0286	0.0286	CcSEcCtD
Ganciclovir—Hepatic failure—Propylthiouracil—Graves' disease	0.0272	0.0272	CcSEcCtD
Ganciclovir—Renal failure acute—Propylthiouracil—Graves' disease	0.0264	0.0264	CcSEcCtD
Ganciclovir—Dermatitis exfoliative—Propylthiouracil—Graves' disease	0.0259	0.0259	CcSEcCtD
Ganciclovir—Neuropathy peripheral—Methimazole—Graves' disease	0.0217	0.0217	CcSEcCtD
Ganciclovir—Jaundice—Methimazole—Graves' disease	0.0216	0.0216	CcSEcCtD
Ganciclovir—Agranulocytosis—Methimazole—Graves' disease	0.0206	0.0206	CcSEcCtD
Ganciclovir—Hepatitis—Methimazole—Graves' disease	0.0199	0.0199	CcSEcCtD
Ganciclovir—Neuropathy peripheral—Propylthiouracil—Graves' disease	0.0184	0.0184	CcSEcCtD
Ganciclovir—Jaundice—Propylthiouracil—Graves' disease	0.0183	0.0183	CcSEcCtD
Ganciclovir—Agranulocytosis—Propylthiouracil—Graves' disease	0.0176	0.0176	CcSEcCtD
Ganciclovir—Alopecia—Methimazole—Graves' disease	0.0176	0.0176	CcSEcCtD
Ganciclovir—Haemoglobin—Propylthiouracil—Graves' disease	0.017	0.017	CcSEcCtD
Ganciclovir—Haemorrhage—Propylthiouracil—Graves' disease	0.0169	0.0169	CcSEcCtD
Ganciclovir—Hepatitis—Propylthiouracil—Graves' disease	0.0169	0.0169	CcSEcCtD
Ganciclovir—Vertigo—Methimazole—Graves' disease	0.0155	0.0155	CcSEcCtD
Ganciclovir—Leukopenia—Methimazole—Graves' disease	0.0155	0.0155	CcSEcCtD
Ganciclovir—Alopecia—Propylthiouracil—Graves' disease	0.0149	0.0149	CcSEcCtD
Ganciclovir—Myalgia—Methimazole—Graves' disease	0.0147	0.0147	CcSEcCtD
Ganciclovir—Arthralgia—Methimazole—Graves' disease	0.0147	0.0147	CcSEcCtD
Ganciclovir—Dysgeusia—Propylthiouracil—Graves' disease	0.0144	0.0144	CcSEcCtD
Ganciclovir—Oedema—Methimazole—Graves' disease	0.0141	0.0141	CcSEcCtD
Ganciclovir—Thrombocytopenia—Methimazole—Graves' disease	0.0138	0.0138	CcSEcCtD
Ganciclovir—Vertigo—Propylthiouracil—Graves' disease	0.0132	0.0132	CcSEcCtD
Ganciclovir—Leukopenia—Propylthiouracil—Graves' disease	0.0132	0.0132	CcSEcCtD
Ganciclovir—Musculoskeletal discomfort—Methimazole—Graves' disease	0.0129	0.0129	CcSEcCtD
Ganciclovir—Paraesthesia—Methimazole—Graves' disease	0.0127	0.0127	CcSEcCtD
Ganciclovir—Somnolence—Methimazole—Graves' disease	0.0125	0.0125	CcSEcCtD
Ganciclovir—Arthralgia—Propylthiouracil—Graves' disease	0.0125	0.0125	CcSEcCtD
Ganciclovir—Myalgia—Propylthiouracil—Graves' disease	0.0125	0.0125	CcSEcCtD
Ganciclovir—Dyspepsia—Methimazole—Graves' disease	0.0124	0.0124	CcSEcCtD
Ganciclovir—Oedema—Propylthiouracil—Graves' disease	0.012	0.012	CcSEcCtD
Ganciclovir—Thrombocytopenia—Propylthiouracil—Graves' disease	0.0117	0.0117	CcSEcCtD
Ganciclovir—Urticaria—Methimazole—Graves' disease	0.0112	0.0112	CcSEcCtD
Ganciclovir—Body temperature increased—Methimazole—Graves' disease	0.0112	0.0112	CcSEcCtD
Ganciclovir—Musculoskeletal discomfort—Propylthiouracil—Graves' disease	0.0109	0.0109	CcSEcCtD
Ganciclovir—Paraesthesia—Propylthiouracil—Graves' disease	0.0108	0.0108	CcSEcCtD
Ganciclovir—Somnolence—Propylthiouracil—Graves' disease	0.0107	0.0107	CcSEcCtD
Ganciclovir—Dyspepsia—Propylthiouracil—Graves' disease	0.0106	0.0106	CcSEcCtD
Ganciclovir—Pruritus—Methimazole—Graves' disease	0.00998	0.00998	CcSEcCtD
Ganciclovir—Urticaria—Propylthiouracil—Graves' disease	0.00953	0.00953	CcSEcCtD
Ganciclovir—Body temperature increased—Propylthiouracil—Graves' disease	0.00949	0.00949	CcSEcCtD
Ganciclovir—Vomiting—Methimazole—Graves' disease	0.00897	0.00897	CcSEcCtD
Ganciclovir—Rash—Methimazole—Graves' disease	0.0089	0.0089	CcSEcCtD
Ganciclovir—Dermatitis—Methimazole—Graves' disease	0.00889	0.00889	CcSEcCtD
Ganciclovir—Headache—Methimazole—Graves' disease	0.00884	0.00884	CcSEcCtD
Ganciclovir—Pruritus—Propylthiouracil—Graves' disease	0.00849	0.00849	CcSEcCtD
Ganciclovir—Nausea—Methimazole—Graves' disease	0.00838	0.00838	CcSEcCtD
Ganciclovir—Vomiting—Propylthiouracil—Graves' disease	0.00763	0.00763	CcSEcCtD
Ganciclovir—Rash—Propylthiouracil—Graves' disease	0.00757	0.00757	CcSEcCtD
Ganciclovir—Dermatitis—Propylthiouracil—Graves' disease	0.00756	0.00756	CcSEcCtD
Ganciclovir—Headache—Propylthiouracil—Graves' disease	0.00752	0.00752	CcSEcCtD
Ganciclovir—Nausea—Propylthiouracil—Graves' disease	0.00713	0.00713	CcSEcCtD
